Cryotherapy with tranexamic acid for melasma treatment
Part of Skin clinical trials.
This trial tests if adding a medicine called tranexamic acid to cryotherapy (a freezing treatment) works better than cryotherapy with salt water for treating melasma, a common skin condition causing dark patches on the face.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have melasma patches at least 2 cm wide on both cheeks.
- Your skin type is II, III, or IV (ranges from fair to olive).
- You are not pregnant or breastfeeding.
- You have not used laser or other energy devices for melasma in the last 6 months.
- You have not used any topical creams or oral medications for melasma in the last 6 months.
- You are not allergic to cold treatments (like cryotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This trial compares two treatments for melasma, a common skin condition causing dark patches on the face. One treatment uses an injection into the affected skin (tranexamic acid), while the other uses a chemical peel (mandelic acid). The study aims to see which works better and is safer for people with darker skin tones.
This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.
This study tests whether combining oral tranexamic acid with a special skin needling treatment helps reduce melasma (dark facial patches). It is designed for women aged 18-50 who have melasma and are not pregnant or on certain medications.
This trial compares two topical creams—tranexamic acid and ethyl ascorbic acid (a form of vitamin C)—to see which works better for melasma, a common skin condition that causes dark patches on the face. The study will help determine which treatment is more effective.
This study tests whether adding an oral medication (tranexamic acid) to a standard triple cream for melasma works better than the cream alone. It may help if you have medium-to-severe melasma and are generally healthy.
Hear when a new Cryotherapy Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.